Erratum: Combined anti-inflammatory and anti-age drug treatments have a protective effect on intervertebral discs in mice with diabetes (PLoS ONE (2013) 8:5 (e64302) doi:10.1371/journal.pone.0064302);Combined Anti-Inflammatory and Anti-AGE Drug Treatments Have a Protective Effect on Intervertebral Discs in Mice with Diabetes

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Illien Junger, Svenja ^a   Grosjean, Fabrizio ^a,b   Laudier, Damien M ^a   Vlassara, Helen ^a   Striker, Gary E ^a   Iatridis, James C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AGGRECANASE 2; COLLAGENASE 3; GLYCOSAMINOGLYCAN; METHYLGLYOXAL; PENTOSAN POLYSULFATE; PYRIDOXAMINE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CONTROLLED STUDY; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INTERVERTEBRAL DISK DEGENERATION; LUMBAR SPINE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; NUCLEUS PULPOSUS; STREPTOZOCIN DIABETES; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; INTERVERTEBRAL DISC DEGENERATION; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISC DEGENERATION; MICE; PYRIDOXAMINE; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877855262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119112     Document Type: Erratum

References (50)

1. (2008) The Burden of Musculoskeletal Diseases in the United States: Prevalence, Societal and Economic Cost. Available: http://www.boneandjointburden.org/: Amer Acad Orthop Surg. pp. 247.
2. Katz JN, (2006) Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am 88 Suppl 2: 21-24.
3. Karppinen J, Shen FH, Luk KD, Andersson GB, Cheung KM, et al. (2011) Management of degenerative disk disease and chronic low back pain. Orthop Clin North Am 42: 513-528, viii.
4. Wang Y, Videman T, Battie MC, (2012) ISSLS Prize Winner: Lumbar Vertebral Endplate Lesions: Associations With Disc Degeneration and Back Pain History. Spine (Phila Pa 1976) 37: 1490-1496.
5. Williams FM, Popham M, Sambrook PN, Jones AF, Spector TD, et al. (2011) Progression of lumbar disc degeneration over a decade: a heritability study. Ann Rheum Dis 70: 1203-1207.
6. Samartzis D, Karppinen J, Mok F, Fong DY, Luk KD, et al. (2011) A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. J Bone Joint Surg Am 93: 662-670.
7. Samartzis D, Karppinen J, Chan D, Luk KD, Cheung KM, (2012) The association of lumbar intervertebral disc degeneration on magnetic resonance imaging with body mass index in overweight and obese adults: a population-based study. Arthritis Rheum 64: 1488-1496.
8. Burner TW, Rosenthal AK, (2009) Diabetes and rheumatic diseases. Curr Opin Rheumatol 21: 50-54.
9. Jeffcoate WJ, Game F, Cavanagh PR, (2005) The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 366: 2058-2061.
10. Robinson D, Mirovsky Y, Halperin N, Evron Z, Nevo Z, (1998) Changes in proteoglycans of intervertebral disc in diabetic patients. A possible cause of increased back pain. Spine (Phila Pa 1976) 23: 849-855 discussion 856.
11. Sakellaridis N, (2006) The influence of diabetes mellitus on lumbar intervertebral disk herniation. Surg Neurol 66: 152-154.
12. Silberberg R, Adler JH, Meier-Ruge W, (1986) Effects of hyperinsulinism and of diabetes on proteoglycans of the intervertebral disc in weanling sand rats. Exp Cell Biol 54: 121-127.
13. Ziv I, Moskowitz RW, Kraise I, Adler JH, Maroudas A, (1992) Physicochemical properties of the aging and diabetic sand rat intervertebral disc. J Orthop Res 10: 205-210.
14. Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM, et al. (2007) Incidence of diabetes in youth in the United States. JAMA 297: 2716-2724.
15. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373: 2027-2033.
16. Monickaraj F, Aravind S, Gokulakrishnan K, Sathishkumar C, Prabu P, et al. (2012) Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem 365: 343-350.
17. Lotan R, Oron A, Anekstein Y, Shalmon E, Mirovsky Y, (2008) Lumbar stenosis and systemic diseases: is there any relevance? J Spinal Disord Tech 21: 247-251.
18. Gruber HE, Gordon B, Norton HJ, Kilburn J, Williams C, et al. (2008) Analysis of cell death and vertebral end plate bone mineral density in the annulus of the aging sand rat. Spine J 8: 475-481.
19. Weiler C, Nerlich AG, Bachmeier BE, Boos N, (2005) Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine (Phila Pa 1976) 30: 44-53 discussion 54.
20. Hoyland JA, Le Maitre C, Freemont AJ, (2008) Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford) 47: 809-814.
21. Le Maitre CL, Hoyland JA, Freemont AJ, (2007) Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther 9: R77.
22. Cai W, Ramdas M, Zhu L, Chen X, Striker GE, et al. (2012) Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci U S A 109: 15888-15893.
23. Semba RD, Nicklett EJ, Ferrucci L, (2010) Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci 65: 963-975.
24. Vlassara H, Striker GE, (2011) AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol 7: 526-539.
25. Nemet I, Turk Z, Duvnjak L, Car N, Varga-Defterdarovic L, (2005) Humoral methylglyoxal level reflects glycemic fluctuation. Clin Biochem 38: 379-383.
26. Sivan SS, Tsitron E, Wachtel E, Roughley P, Sakkee N, et al. (2006) Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs. Biochem J 399: 29-35.
27. Wagner DR, Reiser KM, Lotz JC, (2006) Glycation increases human annulus fibrosus stiffness in both experimental measurements and theoretical predictions. J Biomech 39: 1021-1029.
28. Tang SY, Sharan AD, Vashishth D, (2008) Effects of collagen crosslinking on tissue fragility. Clin Biomech (Bristol, Avon) 23: 122-123 author reply 124-126.
29. Cai W, He JC, Zhu L, Chen X, Zheng F, et al. (2008) Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 173: 327-336.
30. Bucala R, Cerami A, (1992) Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23: 1-34.
31. Urios P, Grigorova-Borsos AM, Sternberg M, (2007) Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen. Diabetes Res Clin Pract 77: 337-340.
32. Tarallo S, Beltramo E, Berrone E, Porta M, (2012) Human pericyte-endothelial cell interactions in co-culture models mimicking the diabetic retinal microvascular environment. Acta Diabetol.
33. Voziyan PA, Hudson BG, (2005) Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage. Cell Mol Life Sci 62: 1671-1681.
34. Masuda K, Aota Y, Muehleman C, Imai Y, Okuma M, et al. (2005) A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine (Phila Pa 1976) 30: 5-14.
35. Millecamps M, Tajerian M, Naso L, Sage EH, Stone LS, (2012) Lumbar intervertebral disc degeneration associated with axial and radiating low back pain in ageing SPARC-null mice. Pain 153: 1167-1179.
36. Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, et al. (2002) Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 55: 91-97.
37. Bobadilla NA, Tack I, Tapia E, Sanchez-Lozada LG, Santamaria J, et al. (2001) Pentosan polysulfate prevents glomerular hypertension and structural injury despite persisting hypertension in 5/6 nephrectomy rats. J Am Soc Nephrol 12: 2080-2087.
38. Wu J, Guan TJ, Zheng S, Grosjean F, Liu W, et al. (2011) Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice. Lab Invest 91: 1459-1471.
39. Ghosh P, Wu J, Shimmon S, Zannettino AC, Gronthos S, et al. (2010) Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells. Arthritis Res Ther 12: R28.
40. Kumagai K, Shirabe S, Miyata N, Murata M, Yamauchi A, et al. (2010) Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis-an open clinical trial. BMC Clin Pharmacol 10: 7.
41. Adrover M, Vilanova B, Frau J, Munoz F, Donoso J, (2008) The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect. Bioorg Med Chem 16: 5557-5569.
42. Giannoukakis N, (2005) Pyridoxamine (BioStratum). Curr Opin Investig Drugs 6: 410-418.
43. Barnett A, (2006) Prevention of loss of renal function over time in patients with diabetic nephropathy. Am J Med 119: S40-47.
44. Chen AC, Temple MM, Ng DM, Verzijl N, DeGroot J, et al. (2002) Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage. Arthritis Rheum 46: 3212-3217.
45. Reiser KM, (1994) Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. J Gerontol 49: B71-79.
46. Sivan SS, Van El B, Merkher Y, Schmelzer CE, Zuurmond AM, et al. (2012) Longevity of elastin in human intervertebral disc as probed by the racemization of aspartic acid. Biochim Biophys Acta 1820: 1671-1677.
47. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
48. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, et al. (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434: 648-652.
49. Yoshida T, Park JS, Yokosuka K, Jimbo K, Yamada K, et al. (2009) Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro. Spine (Phila Pa 1976) 34: 1544-1548.
50. Dahia CL, Mahoney EJ, Durrani AA, Wylie C, (2009) Postnatal growth, differentiation, and aging of the mouse intervertebral disc. Spine (Phila Pa 1976) 34: 447-455.